Literature DB >> 14578757

Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.

Maria Luisa Vampa1, Paul J Norman, Lisa Burnapp, Robert W Vaughan, Steven H Sacks, Wilson Wong.   

Abstract

BACKGROUND: Natural killer (NK) cells use killer immunoglobulin-like receptors (KIR) that bind to self-class I major histocompatibility complex (MHC) molecules to prevent killing of autologous cells. Mismatched allografts, which do not express recipient MHC class I molecules, can therefore be potential targets for NK-cell killing. In our living related-unrelated renal transplantation program, donor-recipient pairs vary in the amount of both HLA and KIR genes they share. This provides us with a unique opportunity to dissect the influence of KIR on NK-cell function after transplantation.
METHODS: Recipient NK cells were used in a cytotoxicity assay against donor peripheral blood mononuclear cells 2 days before, on the day of, and 3 days after transplantation. Results were correlated to HLA-KIR compatibility between donor and recipient.
RESULTS: NK killing, in a direct ex vivo setting, was demonstrated to be HLA mismatch dependent. Recipient NK antidonor cytotoxicity was unaltered despite having received 2 days' treatment with cyclosporine A before transplantation. However, cytotoxicity increased 3 days after transplantation in 71% of recipients. Recipients exhibiting increased NK cytotoxicity against their donors after transplantation were found to possess more activating KIR genes specific for donor class I MHC molecules than those in whom killing activity did not increase (P<0.04).
CONCLUSIONS: NK cells are activated after transplantation despite quadruple immunosuppression, suggesting that recipient NK-cell cytotoxicity against the donor may be a previously unrecognized area of the rejection process, especially in poorly matched donor-recipient pairs where the recipient may not express the correct repertoire of inhibitory receptors to prevent killing of donor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578757     DOI: 10.1097/01.TP.0000083896.91215.C7

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Applying genomics in heart transplantation.

Authors:  Brendan J Keating; Alexandre C Pereira; Michael Snyder; Brian D Piening
Journal:  Transpl Int       Date:  2018-02-12       Impact factor: 3.782

2.  Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection.

Authors:  J R Greenland; N P Jewell; M Gottschall; N N Trivedi; J Kukreja; S R Hays; J P Singer; J A Golden; G H Caughey
Journal:  Am J Transplant       Date:  2014-02-11       Impact factor: 8.086

3.  Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.

Authors:  Lu-En Wai; Masato Fujiki; Saori Takeda; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2008-01-15       Impact factor: 4.939

4.  Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation.

Authors:  Izabela Nowak; Maria Magott-Procelewska; Agnieszka Kowal; Maciej Miazga; Marta Wagner; Wanda Niepiekło-Miniewska; Małgorzata Kamińska; Andrzej Wiśniewski; Edyta Majorczyk; Marian Klinger; Wioleta Łuszczek; Andrzej Pawlik; Rafał Płoski; Ewa Barcz; David Senitzer; Piotr Kuśnierczyk
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studies.

Authors:  Yun R Li; Jessica van Setten; Shefali S Verma; Yontao Lu; Michael V Holmes; Hui Gao; Monkol Lek; Nikhil Nair; Hareesh Chandrupatla; Baoli Chang; Konrad J Karczewski; Chanel Wong; Maede Mohebnasab; Eyas Mukhtar; Randy Phillips; Vinicius Tragante; Cuiping Hou; Laura Steel; Takesha Lee; James Garifallou; Toumy Guettouche; Hongzhi Cao; Weihua Guan; Aubree Himes; Jacob van Houten; Andrew Pasquier; Reina Yu; Elena Carrigan; Michael B Miller; David Schladt; Abdullah Akdere; Ana Gonzalez; Kelsey M Llyod; Daniel McGinn; Abhinav Gangasani; Zach Michaud; Abigail Colasacco; James Snyder; Kelly Thomas; Tiancheng Wang; Baolin Wu; Alhusain J Alzahrani; Amein K Al-Ali; Fahad A Al-Muhanna; Abdullah M Al-Rubaish; Samir Al-Mueilo; Dimitri S Monos; Barbara Murphy; Kim M Olthoff; Cisca Wijmenga; Teresa Webster; Malek Kamoun; Suganthi Balasubramanian; Matthew B Lanktree; William S Oetting; Pablo Garcia-Pavia; Daniel G MacArthur; Paul I W de Bakker; Hakon Hakonarson; Kelly A Birdwell; Pamala A Jacobson; Marylyn D Ritchie; Folkert W Asselbergs; Ajay K Israni; Abraham Shaked; Brendan J Keating
Journal:  Genome Med       Date:  2015-10-01       Impact factor: 11.117

6.  Design and Implementation of the International Genetics and Translational Research in Transplantation Network.

Authors: 
Journal:  Transplantation       Date:  2015-11       Impact factor: 4.939

Review 7.  Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytology.

Authors:  Nicole E Speck; Macé M Schuurmans; Christian Murer; Christian Benden; Lars C Huber
Journal:  Respir Res       Date:  2016-06-21

8.  KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.

Authors:  Roberto Littera; Gianbenedetto Piredda; Davide Argiolas; Sara Lai; Elena Congeddu; Paola Ragatzu; Maurizio Melis; Elisabetta Carta; Maria Benigna Michittu; Donatella Valentini; Luisella Cappai; Rita Porcella; Francesco Alba; Maria Serra; Valentina Loi; Roberta Maddi; Sandro Orrù; Giorgio La Nasa; Giovanni Caocci; Roberto Cusano; Marcella Arras; Mauro Frongia; Antonello Pani; Carlo Carcassi
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

9.  Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study.

Authors:  Jun Tao; Li Sun; Zijie Wang; Hao Chen; Zhijian Han; Hengcheng Zhang; Haiwei Yang; Zhengkai Huang; Shuang Fei; Xiaobin Ju; Ruoyun Tan; Min Gu
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.